Connective tissue growth factor (CTGF) from basics to clinics

Y Ramazani, N Knops, MA Elmonem, TQ Nguyen… - Matrix Biology, 2018 - Elsevier
Connective tissue growth factor, also known as CCN2, is a cysteine-rich matricellular protein
involved in the control of biological processes, such as cell proliferation, differentiation …

The Broad Spectrum of LMNA Cardiac Diseases: From Molecular Mechanisms to Clinical Phenotype

S Crasto, I My, E Di Pasquale - Frontiers in physiology, 2020 - frontiersin.org
Mutations of Lamin A/C gene (LMNA) cause laminopathies, a group of disorders associated
with a wide spectrum of clinically distinct phenotypes, affecting different tissues and organs …

Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations

C Le Dour, M Chatzifrangkeskou, C Macquart… - Nature …, 2022 - nature.com
Mutations in the lamin A/C gene (LMNA) cause dilated cardiomyopathy associated with
increased activity of ERK1/2 in the heart. We recently showed that ERK1/2 phosphorylates …

Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy

RJ Chai, H Werner, PY Li, YL Lee, KT Nyein… - Nature …, 2021 - nature.com
Mutations in the LaminA gene are a common cause of monogenic dilated cardiomyopathy.
Here we show that mice with a cardiomyocyte-specific Lmna deletion develop cardiac failure …

[HTML][HTML] Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases

M Fu, D Peng, T Lan, Y Wei, X Wei - Acta Pharmaceutica Sinica B, 2022 - Elsevier
Connective tissue growth factor (CTGF), a multifunctional protein of the CCN family,
regulates cell proliferation, differentiation, adhesion, and a variety of other biological …

From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy

RJA Veltrop, MM Kukk, K Topouzidou, L Didden… - Cell Communication and …, 2024 - Springer
Severe cardiac remodeling leading to heart failure in individuals harboring pathogenic
LMNA variants, known as cardiolaminopathy, poses a significant clinical challenge …

Non-ischemic dilated cardiomyopathy and cardiac fibrosis

BO Cojan-Minzat, A Zlibut, L Agoston-Coldea - Heart Failure Reviews, 2021 - Springer
Cardiac fibrosis is associated with non-ischemic dilated cardiomyopathy, increasing its
morbidity and mortality. Cardiac fibroblast is the keystone of fibrogenesis, being activated by …

Epigenetics in LMNA-Related Cardiomyopathy

Y Wang, G Dobreva - Cells, 2023 - mdpi.com
Mutations in the gene for lamin A/C (LMNA) cause a diverse range of diseases known as
laminopathies. LMNA-related cardiomyopathy is a common inherited heart disease and is …

Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact

IG Lunde, KB Rypdal, S Van Linthout, J Diez… - Matrix Biology, 2024 - Elsevier
Fibrosis is defined by the excessive accumulation of extracellular matrix (ECM) and
constitutes a central pathophysiological process that underlies tissue dysfunction, across …

[PDF][PDF] Crosstalk between TGF-β and WNT signalling pathways during cardiac fibrogenesis

E Działo, K Tkacz, P Błyszczuk - Acta Biochimica Polonica, 2018 - frontierspartnerships.org
Cardiac fibrosis is referred to as an excessive accumulation of stromal cells and extracellular
matrix proteins in the myocardium. Progressive fibrosis causes stiffening of the cardiac …